Studies on the mechanism of uptake of liposomes using an isolated perfused liver system

Journal of Liposome Research

Volumn 6, Issue 1, 1996, Pages 61-75

  Harashima, Hideyoshi ^a   Kiwada, Hiroshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; DICETYL PHOSPHATE; LIPOSOME; MANNOSE RECEPTOR; OPSONIN; PHOSPHATIDYLCHOLINE;

ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; DRUG UPTAKE; KUPFFER CELL; LIPID COMPOSITION; LIVER CELL; MEMBRANE VESICLE; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

EID: 0029942607     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109609037202     Document Type: Article

References (34)

1. Darnell, J. Lodish, H., and Baltimore, D. 1990. The internalization of macromolecules and particles. In Molecular Cell Biology 2nd Ed., Scientific American Books, New York, pp. 555.
2. Pratten, M. K., and Lloyd, J. B. 1986. Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim. Biophys. Acta 881: 307.
3. Steinman, R. M., Brodic, S. E., and Cohn, Z. A. 1976. Membrane flow during pinocytosis: Astereologic analysis. J. Cell Biol. 68: 665.
4. Brown, E. J. 1991. Complement receptors and phagocytosis. Cur. Opin. Immun. 3: 76.
5. Metzger, H. 1991. Fc receptors and membrane immunoglobulin. ibid. 3: 40.
6. Ookhtens, M. and Kaplowitz, N. 1990. The use of isolated perfused liver in studies of biological transport processes. Methods in Enzymol. 192: 485
7. Kiwada, H., Obara, S., Nishiwaki, H., and Kato, Y. 1986. Studies on the uptake mechanism of liposomes by perfused rat liver. I. An investigation of effluent profiles with perfusate containing no blood component. Chem. Pharm. Bull. 34: 1249.
8. Kiwada, H., Miyajima, T., and Kato, Y. 1987. Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum. Chem. Pharm. Bull. 35: 1189.
9. Tahara, K. Hayashi, M., Awazu, S., Kato, Y., and Kiwada, H. 1989. Effect of serum on dose- and temperature-dependent hepatic uptake of multilamellar vesicles (MLV). J. Pharmacobio-Dyn. 12: 596.
10. Abra, R. M., and Hunt, C. A. 1981. Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim. Biophys. Acta 666: 493.
11. Sato, Y., Kiwada, H., and Kato, Y. 1986. Effects of dose and vesicle size on the pharmacokinetics of liposomes. Chem. Pharm. Bull. 34: 4244.
12. Kume, Y., Maeda, F., Harashima, H., and Kiwada, H. 1991. Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system. J. Pharm. Pharmacol. 43:162.
13. Patel, H. M. 1992. Serum opsonins and liposomes: Their interaction and opsonophagocytosis. CRC Crit. Rev. Ther. Drug Carrier Sys. 9: 39
14. Saba, T. M. 1970. Physiology and physiopathology of the reticuloendothelial system. Arch Intern. Med. 126. 1031
15. Harashima, H., Sakata, K., and Kiwada, H. 1993. Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic up take of liposomes. Pharm. Res. 10: 606.
16. Funato, K., Yoda, R., and Kiwada, H. 1992. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta, 1103: 198.
17. Devine, D. V., Wong, K., Serrano, K. Chonn, A., and Cullis, P. R. 1994. Liposome-complement interaction in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta 1191. 43
18. Scieszka, J. F., Maggiora, L. L., Wright, S. D., and Cho, M. J. 1991. Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils. Pharm. Res. 8, 65-69 (1991).
19. Harashima, H., Sakata, K., Funato K., and Kiwada, H. 1994. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 11. 402.
20. Wright, S. D., and Silverstwin, S. C. 1982. Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 156: 1149.
21. Miyazaki, W., Tamaoka, H., Shinohara, M., Kaise, H., Izawa, T., Nakano, Y., Kinoshita, Hong, K., and Inoue, K. 1980. A complement inhibitor produced by Stachybotrys complementi, nov. sp. K-76, a new species of fungiimperfecti. Microbiol. Immunol. 24: 1091.
22. Senior, J. H. 1987. Fate and behavior of liposomes in vivo: A review of controlling factors. CRC Crit. Rev. Ther. Drug Carrier Sys., 3: 123.
23. Harashima, H., Ochi, Y., and Kiwada, H. 1994. Kinetic modeling of liposome degradation in serum: Effect of size and concentration of liposomes in vitro. Biopharm. Drug Disposit. 15: 217.
24. Harashima, H., Yamane, C., Kume, Y., and Kiwada, H. 1993. Kinetic analysis of AUC-dependent saturable clearance of liposomes: Mathematical description of AUC dependency. J. Pharmacokin. Biopharm. 21: 299.
25. Liu, Z., R. Solow, R., and Hu, V. W. 1988. Fluorescence analysis of size distribution and mode of dye release from carboxyfluorescein-loaded vesicles: application to the study of complement-membrane interactions. Biochim. Biophys. Acta 945: 253.
26. Funato, K. Yamashita, C., Kamada, J., Tominaga, S., and Kiwada, H. 1994. Plasma factor triggering alternative complement pathway activation by liposomes. Pharm. Res. 11: 372.
27. Harashima, H., Ohnishi, Y., and Kiwada, H. 1992. In vivo evaluation of the effect of the size and opsonization on the hepatic extraction of liposomes in rats: An application of Oldendorf method. Biopharm. Drug Disp. 13: 549.
28. Kiwada, H., Niimura, H., and Kato, Y. 1985. Tissue distribution and pharmacokinetic evaluation of the targeting efficiency of synthetic alkyl glycoside vesicles. Chem. Pharm. Bull. 33: 2475.
29. Osaka, S., Tsuji, H. and Kiwada, H. 1994. Uptake of liposomes surface-modified with glycyrrhizin by primary cultured rat hepatocytes. Biol. Pharm. Bull. 17: 940.
30. Kiwada, H. Nakajima, I., Matsuura, H., Tsuji, M., and Kato, Y. 1988. Application of synthetic alkyl glycoside vesicles as drug carriers. III. Plasma components affecting stability of the vesicles. Chem. Pharm. Bull. 36: 1841.
31. Yamashita, C., Matsuo, H., Akiyama, K., and Kiwada, H. 1991. Enhancing effect of cetylmannoside on targeting of liposomes to Kupffer cells in rats. Int. J. Pharm. 70: 225.
32. Matsuo, H., Funato, K., Harashima, H., and Kiwada, H. 1994. The complement- but not mannose receptor mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ. J. Drug Targ. 2: 141.
33. Ishida, T., Shinohara, M., Iwata, F., Ohmoto, Y., and Kiwada, H. 1994. Quantitative determination of C3 fragments on the liposomal surface with anti-human C3 monoclonal antibodies. Drug Delivery Sys. 9: 25
34. Harashima, H., Komatsu, S., Kojima, S., Yanagi, C., Naito, M., and Kiwada, H. Species difference in the disposition of liposomes among mice, rats and rabbits: Allometric relationship and species dependent hepatic uptake clearance. (submitted)